Results A total of 579 studies were identified by the electronic search. Of these, a total of 187
were identified as eligible papers including 60,319 patients who were meta-analyzed for …

Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern
Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis …

New technologies are supported by the global implementation of the internet. These
improvements have deeply affected various disciplines of sciences and consequently …

The hepatitis C virus (HCV) is a major global health challenge and a leading cause of
morbidity and mortality. Many direct-acting antivirals (DAAs) target essential …

Background Viral resistance-associated substitutions (RASs) can develop in the setting of
DAAs therapy (ie, emerging RASs). Long-term monitoring of fibrosis regression after …

Nucleotide sequencing of the phylogenetically informative region of NS5B remains the gold
standard for hepatitis C virus (HCV) genotyping. Here we developed a new methodology for …

Abstract Background Hepatitis C virus (HCV) genotyping is required for tailoring the dose
and duration of antiviral therapy, predicting virological response rates, and selecting future …

Blood safety remains a paramount public health concern, and health authorities maintain a
high level of vigilance to prevent transfusion-transmitted infections (TTIs)[1]. Rigorous …

Chronic hepatitis C virus (HCV) infection is a main health problem in Egypt causing high
rates of mortalities. Egypt has the highest HCV prevalence in the world, with specific HCV …

While the prospect of viral cure is higher than ever for individuals infected with the hepatitis
C virus (HCV) due to ground-breaking progress in antiviral treatment, success rates are still …